Cara Therapeutics Inc
For the period ended Dec 31, 2024. Filed Mar 11, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 11, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 14. Principal Accounting Fees and Services
The following table represents aggregate fees billed to the Company for the fiscal years ended December 31, 2024 and 2023 by Ernst & Young LLP, the Company’s principal accountant.
| · · · · · · | ||||
|---|---|---|---|---|
| | Fiscal Year Ended December 31, | |||
| Fee Category · 2024 · 2023 | ||||
| Audit fees(1) | | $660 | | $817 |
| Audit-related fees(2) | | 320 | | 222 |
| Total fees | | $980 | | $1,039 |
| (1) | “Audit fees” for the years ended December 31, 2024 and 2023 consist of the aggregate fees billed for professional services rendered for (i) the audit of the consolidated financial statements included in our annual report on Form 10-K for that year; and (ii) the review of our quarterly reports on Form 10-Q for each of the first three quarters of that year. |
| (2) | “Audit-related fees” for the years ended December 31, 2024 and 2023 consist of the aggregate fees billed for professional services rendered for accounting consultations. |
All fees described above for the years ended December 31, 2024 and 2023 were pre-approved by the Audit Committee.
Pre-Approval Policies and Procedures
The Audit Committee has adopted a policy and procedures for the pre-approval of audit and non-audit services rendered by the Company’s independent registered public accounting firm, Ernst & Young LLP. The policy generally pre-approves specified services in the defined categories of audit services, audit-related services and tax services up to specified amounts. Pre-approval may also be given as part of the Audit Committee’s approval of the scope of the engagement of the independent auditor or on an individual, explicit, case-by-case basis before the independent auditor is engaged to provide each service. The pre-approval of services may be delegated to one or more of the Audit Committee’s members, but the decision must be reported to the full Audit Committee at our next scheduled meeting.
The Audit Committee has determined that the rendering of services other than audit services by Ernst & Young LLP is compatible with maintaining the principal accountant’s independence.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.